Microbiome contract manufacturing Market Headed for Growth and Global Expansion by 2030


Posted August 5, 2020 by charlottefraser21

The microbiome therapies pipeline features 260 drugs under evaluation across different phases of development; contract service providers have become an integral part of the supply chain owing to their technical expertise, claims Roots Analysis

 
Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

The USD 300 million (by 2030) financial opportunity within the microbiome contract manufacturing market has been analysed across the following segments:

Type of Product Manufactured
• Active Pharmaceutical Ingredients (APIs)
• Finish Drug Formulations (FDFs)

Type of Type of Formulation
• Solid Formulations
• Oral Liquids
• Injectables
• Others

Scale of Operation
• Clinical
• Commercial

Company Size
• Small-sized
• Mid-sized
• Large

Key Geographical Regions
• North America
• Europe
• Asia-Pacific and Rest of the World

The Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
• Bristol Myers Squibb
• GlaxoSmithKline
• Incyte
• Novartis
• Trillium Therapeutics

Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Profiles
6. Regional Capability Analysis
7. Likely Partner Analysis
8. Clinical Trial Analysis
9. Capacity Analysis
10. Demand Analysis
11. Make versus Buy Decision Making Framework
12. Microbiome related initiatives of Big Pharmaceutical Players
13. Market Forecast
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
18. Appendix 3: List of Probiotic Supplement Contract Manufacturers and
Microbial Contract Service Providers

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Roots Analysis
Phone 4158003415
Business Address Sacramento Los Angeles Beverly Hills
Country United States
Categories Business , Industry , Research
Tags microbiome contract manufacturing , microbiome contract manufacturing market , microbiome contract manufacturing market size
Last Updated August 5, 2020